Today (March 4) afternoon, the first "Committee Channel" of the Third Session of the 14th National Committee of the Chinese People's Political Consultative Conference was held in the Great Hall of the People. Zhao Hong, a member of the National Committee of the Chinese People's Political Consultative Conference and chief physician of the Cancer Hospital of the Chinese Academy of Medical Sciences, accepted an interview with reporters.
Zhao Hong introduced that as a doctor who has been working on the front line of clinical practice, I would like to ask what my biggest feeling in recent years is that it has caught up with a good time for the innovative development of China's biomedical medicine. In the past year, the country has approved 48 new drugs and 65 devices, and the number of new drugs under development has also ranked second in the world. Recently, there was a news that a new drug produced by an unknown Chinese company defeated the world's best-selling anti-cancer drug. This is actually just a microcosm. We have seen more domestic targeted and immune cell therapy drugs successfully go overseas. High-end medical equipment such as surgical robots and artificial hearts developed independently have also been released one after another. It should be said that in this field, we have embarked on a prosperous road from imitation to innovation and from weak to strong.
